guest :: login
DKFZ
    Search   Submit  
Personalize
  • Your alerts
  • Your baskets
  • Your searches
  Help    
Home > Publications database > Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients. > Access to Fulltext
  • Information
  • Files
 
 
Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients. - DKFZ-2024-00057
 
Main document file(s):
      Pediatric Blood Cancer - 2024 - Stepien - Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three
    version 1
    Pediatric Blood Cancer - 2024 - Stepien - Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three.pdf [2.15 MB] 23 May 2025, 13:17
    Pediatric Blood Cancer - 2024 - Stepien - Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three.pdf (pdfa) [550.36 KB] 23 May 2025, 13:19
Similar records

DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2508a
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy